rs370820622

Variant names:

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_000548.5(TSC2):c.5331T>C(p.Pro1777Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,612,478 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)

Exomes 𝑓: 0.000023 ( 0 hom. )

Consequence

TSC2
NM_000548.5 synonymous

Scores

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: -1.76

Publications

1 publications found

Variant links:

COSMIC-nc: COSV104375809

Genes affected

TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]

TSC2 links:

PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]

PKD1 Gene-Disease associations (from GenCC):

autosomal dominant polycystic kidney disease
Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
polycystic kidney disease 1
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
autosomal recessive polycystic kidney disease
Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
Caroli disease
Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp

PKD1 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.86).

BP6

Variant 16-2088517-T-C is Benign according to our data. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2088517-T-C is described in CliVar as Benign/Likely_benign. Clinvar id is 65127.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

BP7

Synonymous conserved (PhyloP=-1.76 with no splicing effect.

BS2

High AC in GnomAd4 at 5 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
TSC2	NM_000548.5 link	c.5331T>C	p.Pro1777Pro	synonymous_variant	Exon 42 of 42	ENST00000219476.9	NP_000539.2	P49815-1
PKD1	NM_001009944.3 link	c.*1210A>G		downstream_gene_variant		ENST00000262304.9	NP_001009944.3

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
TSC2	ENST00000219476.9 link	c.5331T>C	p.Pro1777Pro	synonymous_variant	Exon 42 of 42	5	NM_000548.5	ENSP00000219476.3		P49815-1
PKD1	ENST00000262304.9 link	c.*1210A>G		downstream_gene_variant		1	NM_001009944.3	ENSP00000262304.4		P98161-1

Frequencies

GnomAD3 genomes

AF:

0.0000329

AC:

AN:

152060

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0000242

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.0000294

Gnomad OTH

AF:

0.000958

GnomAD2 exomes

AF:

0.0000160

AC:

AN:

249840

AF XY:

0.0000221

show subpopulations

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.000300

Gnomad EAS exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00000888

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.0000233

AC:

AN:

1460418

Hom.:

Cov.:

AF XY:

0.0000275

AC XY:

AN XY:

726506

show subpopulations

African (AFR)

AF:

0.000418

AC:

AN:

33478

American (AMR)

AF:

0.0000224

AC:

AN:

44716

Ashkenazi Jewish (ASJ)

AF:

0.000115

AC:

AN:

26136

East Asian (EAS)

AF:

0.00

AC:

AN:

39700

South Asian (SAS)

AF:

0.00

AC:

AN:

86252

European-Finnish (FIN)

AF:

0.00

AC:

AN:

52044

Middle Eastern (MID)

AF:

0.000173

AC:

AN:

5768

European-Non Finnish (NFE)

AF:

0.00000540

AC:

AN:

1111948

Other (OTH)

AF:

0.000149

AC:

AN:

60376

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.488

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.0000329

AC:

AN:

152060

Hom.:

Cov.:

AF XY:

0.0000269

AC XY:

AN XY:

74286

show subpopulations

African (AFR)

AF:

0.0000242

AC:

AN:

41400

American (AMR)

AF:

0.00

AC:

AN:

15270

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3470

East Asian (EAS)

AF:

0.00

AC:

AN:

5178

South Asian (SAS)

AF:

0.00

AC:

AN:

4824

European-Finnish (FIN)

AF:

0.00

AC:

AN:

10612

Middle Eastern (MID)

AF:

0.00

AC:

AN:

316

European-Non Finnish (NFE)

AF:

0.0000294

AC:

AN:

67990

Other (OTH)

AF:

0.000958

AC:

AN:

2088

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.515

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.000158

Hom.:

Bravo

AF:

0.0000453

Asia WGS

AF:

0.000577

AC:

AN:

3478

ClinVar

Significance: Benign/Likely benign

Submissions summary: Benign:8Other:1

Revision: criteria provided, multiple submitters, no conflicts

LINK: link

Submissions by phenotype

Tuberous sclerosis 2

Benign:3

Jan 20, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Nov 07, 2021

Genome-Nilou Lab

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Jun 09, 2025

Myriad Genetics, Inc.

Significance:Benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. -

Hereditary cancer-predisposing syndrome

Benign:2

Jul 07, 2021

Sema4, Sema4

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:curation

- -

Jun 24, 2016

Ambry Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Tuberous sclerosis syndrome

Benign:1Other:1

Jul 29, 2024

All of Us Research Program, National Institutes of Health

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Tuberous sclerosis database (TSC2)

Significance:not provided

Review Status:no classification provided

Collection Method:curation

- -

Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1860707:Tuberous sclerosis 2

Benign:1

Nov 24, 2021

Fulgent Genetics, Fulgent Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not provided

Benign:1

Feb 24, 2021

GeneDx

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.86

CADD

Benign

0.067

(source)

DANN

Benign

0.49

PhyloP100

-1.8

RBP_binding_hub_radar

0.0

RBP_regulation_power_radar

1.1

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over